Chemcon Speciality Chemicals Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹66Cr
- +24.2% YoY
- −11.8% QoQ
- Net profit
- ₹11Cr
- +71.5% YoY
- +72.1% QoQ
- Margin
- 23.21%
- +8.7 pp YoY
- +11.4 pp QoQ
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Chemcon Speciality Chemicals Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q1 FY27 Revenue from Operations: Rs. 66.5 Cr, up 24% YoY from Rs. 53.5 Cr in Q1 FY26 (Page 7). Quarterly EBITDA: ₹15.4 Cr (Q1 FY27), up 98% YoY from ₹7.7 Cr (Q1 FY26).
From Chemcon Speciality Chemicals Ltd's Q1 FY27 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q1 FY27 Revenue from Operations: Rs. 66.5 Cr, up 24% YoY from Rs. 53.5 Cr in Q1 FY26 (Page 7).
- Q1 FY27 Sales Volume: Total 3,302 MT (Organic Chemicals: 2,066 MT; Inorganic Chemicals: 1,236 MT) (Page 6).
- Q1 FY26 Sales Volume: Total 3,434 MT (Organic Chemicals: 2,098 MT; Inorganic Chemicals: 1,336 MT), indicating a slight volume decline YoY (Page 6).
- Outlook: The presentation states optimism about growth prospects driven by improving realizations, traction across newer products, and stronger customer engagement. It notes uncertainties due to global macroeconomic and geopolitical factors (Page 5).
Profitability & Margins
See what Chemcon Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Plan to add manufacturing capacity at the P11 unit dedicated to organic chemicals (Page 19, 17).
- Capacity expansion aims to manufacture organic chemicals such as HMDS, CMIC, Bromobenzene, 2 Bromo (Page 17).
- Timeline for new product launches: Bromobenzene business commenced in 2023, 2-Bromo business started in 2025 (Page 13).
- FY22–24 period saw acquisition of Shivam Petrochem Industries and increased capacity via commissioning plants P7, P8, and P9 (Page 10).
2 more points from Chemcon Speciality Chemicals Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chemcon Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Chemcon Speciality Chemicals Ltd — Quarterly revenue & net profit
Chemcon Speciality Chemicals Ltd Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 66 | 54 | +24.2% | 75 | -11.8% |
| Operating profit (EBITDA) | 15 | 8 | +98.6% | 9 | +73.8% |
| Operating margin | 23.21% | 14.52% | +8.7 pp | 11.77% | +11.4 pp |
| Profit before tax | 15 | 8 | +72.6% | 9 | +65.5% |
| Net profit (PAT) | 11 | 6 | +71.5% | 6 | +72.1% |
| EPS (₹) | 2.99 | 1.74 | +71.8% | 1.74 | +71.8% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹65 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chemcon Speciality Chemicals's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Chemcon Speciality Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Chemcon Speciality Chemicals Ltd Q1 FY27 results?
Q1 FY27 Revenue from Operations: Rs. 66.5 Cr, up 24% YoY from Rs. 53.5 Cr in Q1 FY26 (Page 7). Quarterly EBITDA: ₹15.4 Cr (Q1 FY27), up 98% YoY from ₹7.7 Cr (Q1 FY26).
What is Chemcon Speciality Chemicals Ltd share price analysis?
Chemcon Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 28.1 with a market cap of ₹793 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chemcon Speciality Chemicals Ltd planning capital expenditure?
Plan to add manufacturing capacity at the P11 unit dedicated to organic chemicals (Page 19, 17).
Keep Chemcon Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
